Fibroblast growth factor 23 is associated with fractional excretion of sodium in patients with chronic kidney disease

Abstract

FGF23 is independently associated with increased FENa in non-dialysis CKD patients. These data do not support the notion that FGF23 causes clinically significant sodium retention. Further studies are warranted to explore the mechanism underlying this association.